“Bad” cholesterol cut almost in half in patients with heart conditions using combination therapy with a new drug
Wednesday 14 May 2025, Cleveland: Recent findings by Cleveland Clinic physicians show that combining a new drug, obicetrapib, with a widely used medicine, ezetimibe, reduced low-density lipoprotein (LDL) cholesterol levels by 48.6% after about…
See more “Bad” cholesterol cut almost in half in patients with heart conditions using combination therapy with a new drug